Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
CANCER RESEARCH
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis
. 82:3774-3784.
2022
Abstract 1442: Discovery of recurrence and prognosis associated genes in prostate cancer
. 82:1442-1442.
2022
Abstract 2400: Fucosyltransferase expression is associated with head and neck cancer survival
. 82:2400-2400.
2022
Abstract 2431: A novel role of MUC5AC/CD44v6/c-Met axis in breast cancer brain metastasis
. 82:2431-2431.
2022
Abstract 361: MicroRNA expression in murine spontaneous non-small cell lung cancer and human cell lines post-treatment of PRIMA-1
. 82:361-361.
2022
Abstract 4103: Feasibility and efficacy of a functional precision medicine approach in the management of relapsed/refractory childhood cancers
. 82:4103-4103.
2022
Abstract 6184: Kras Co-mutations lead to resistance to mutant TP53 targeted therapy in mouse models of spontaneous non-small cell lung cancer
. 82:6184-6184.
2022
Abstract 779: A NRF1-driven JRK-mediated β-catenin transcriptional activity contributes to the aggressive growth of ovarian cancer
. 82:779-779.
2022
Abstract 815: Regulation of p53 by INPP4B and high fat diet in mouse prostate
. 82:815-815.
2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
. 82:1321-1339.
2022
Abstract 1351: Targeting mutant p53 protein in spontaneous non-small cell lung cancers in transgenic mice
. 81:1351-1351.
2021
Abstract 2916: Characterization of a mouse model of leptomeningeal melanocytic disease
. 81:2916-2916.
2021
Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction
. 80:3492-3506.
2020
Abstract 3956: Dystroglycan receptor and FER maintain melanoma dormancy in the vascular niche
. 80:3956-3956.
2020
Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
. 79:625-638.
2019
Abstract 938: Estrogen induced NRF1 signaling is a molecular mechanism underlying the generation of different breast cancer stem cell subpopulations leading to intratumoral heterogeneity
. 77:938-938.
2017
Radiation-induced enhancement of antitumor T-cell immunity by VEGF-targeted 4-1BB costimulation
. 77:1310-1321.
2017
Abstract 3312: Transcriptional regulation of chemokine receptor 4 (CXCR4) by nuclear respiratory factor 1 (NRF1) controls estrogen-induced malignant transformation of breast epithelial cells to breast cancer stem cells
. 76:3312-3312.
2016
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
. 76:3978-3988.
2016
EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape
. 76:1284-1296.
2016
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression
. 76:491-504.
2016
Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation
. 73:942-952.
2013
Abstract 2616: The immunoproteasome subunit LMP2 as a novel therapeutic target for non-small cell lung cancer
. 71:2616-2616.
2011
Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate Cancer
. 71:572-582.
2011
Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.
. 70:7543-7552.
2010
Abstract 2631: Target validation of the LMP2 inhibitor, UK-101
. 70:2631-2631.
2010
Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target
. 70:2749-2758.
2010
Epigenetic inactivation of the HOXA gene cluster in breast cancer
. 66:10664-10670.
2006
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer
. 66:10594-10602.
2006
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression
. 65:7959-7967.
2005
CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity
. 65:5812-5817.
2005
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells
. 65:5750-5760.
2005
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
. 65:2378-2386.
2005
Prostaglandin E
2
enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2
. 64:7439-7446.
2004
Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells
. 64:5311-5321.
2004
Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin
. 64:5261-5269.
2004
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
. 64:920-927.
2004
Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells
. 63:2416-2424.
2003
Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1α
. 62:6357-6361.
2002
Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays
. 62:3466-3476.
2002
Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8
+
tumor-reactive T-cell ligands: A comparative analysis of PS-SCL recognition by a single tumor-reactive CD8
+
cytolytic T-lymphocyte clone
. 62:2058-2063.
2002
Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes
. 61:5153-5160.
2001
Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy
. 61:4272-4277.
2001
Randomized trial of supplemental β-carotene to prevent second head and neck cancer
. 61:1457-1463.
2001
Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines
. 59:2718-2723.
1999
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology
. 56:3967-3974.
1996
DEVELOPMENT OF A HUMANIZED DISULFIDE-STABILIZED ANTI-BETA-P185(HER2) FV-BETA-LACTAMASE FUSION PROTEIN FOR ACTIVATION OF A CEPHALOSPORIN DOXORUBICIN PRODRUG
. 55:63-70.
1995
Elevated 8-Hydroxydeoxyguanosine Levels in DNA of Diethylstilbestrol-treated Syrian Hamsters: Covalent DNA Damage by Free Radicals Generated by Redox Cycling of Diethylstilbestrol
. 51:3882-3885.
1991
Changes in Activities of Free Radical Detoxifying Enzymes in Kidneys of Male Syrian Hamsters Treated with Estradiol
. 49:1475-1480.
1989
Characterization of drug metabolism enzymes in estrogen-induced kidney tumors in male syrian hamsters
. 48:5726-5729.
1988
Characteristics of Rat Chloroma Cells in Permanent Suspension Culture
. 35:337-337.
1975
A NRF1-driven JRK-mediated β-catenin transcriptional activity contributes to the aggressive growth of ovarian cancer
2022
Feasibility and efficacy of a functional precision medicine approach in the management of relapsed/refractory childhood cancers
2022
Fucosyltransferase expression is associated with head and neck cancer survival
2022
Regulation of p53 by INPP4B and high fat diet in mouse prostate
2022
Abstract 2004: Understanding the role of α1,2-fucosylation in head and neck cancer
2021
Abstract 2497: Inositol Polyphosphate 4-Phosphatase Type-II B protects mice from benign prostatic hyperplasia
2021
Abstract 2609: Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality
2021
Abstract 878: Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study
2021
Characterization of a mouse model of leptomeningeal melanocytic disease.
2021
Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study.
2021
Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality.
2021
Inositol Polyphosphate 4-Phosphatase Type-II B protects mice from benign prostatic hyperplasia.
2021
Targeting mutant p53 protein in spontaneous non-small cell lung cancers in transgenic mice.
2021
Understanding the role of α1,2-fucosylation in head and neck cancer.
2021
Aberrant transcription factor activity of NRF1, NFE2L2, E2F1, RFX1, and MEF2 associated with severity of astrocytoma
2020
Deregulation of mTOR signaling contributes to chemoradiation resistance in lung squamous cell carcinoma
2020
Inhibition of beta-catenin/CBP signaling alters EGFR fucosylation status in head and neck squamous cell carcinoma
2020
Mutant TP53 action in lung dictated by the cell microenvironment
2020
Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer
2020
Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer
2020
Abstract 2568: Investigation of Fanconi Anemia pathway downstream genes
2019
Abstract 3546: miRNA expression of spontaneous non-small cell lung cancers in p53 mutant transgenic mice following exposure to PRIMA-1
2019
Abstract 3548: Differential miRNA expression levels and risk of lung adenocarcinoma in transgenic mice
2019
Association between NRF1 regulatory gene networks and cancer and aging
2019
Deciphering the role of protein glycosylation in oral cancer: insights into tumor biology and treatment
2019
Differential miRNA expression levels and risk of lung adenocarcinoma in transgenic mice
2019
Investigation of Fanconi Anemia pathway downstream genes
2019
miRNA expression of spontaneous non-small cell lung cancers in p53 mutant transgenic mice following exposure to PRIMA-1
2019
Expanded panel testing superior to BRCA1/2 and breast cancer panel in patients with breast cancer
2019
Underdiagnosis of HBOC in breast cancer patients: Are genetic testing guidelines a tool or an obstacle?
2019
Abstract 2516: Inhibition of Β-catenin/CBP signaling in oral cancer alters EGFR N-glycosylation and abundance
2018
Abstract 4092: Glycosyltransferase ST6Gal-I promotes pancreatic ductal adenocarcinoma progression and metastasis
2018
Abstract 4702: Upgrading cancer immunotherapy: Checkpoint blockade mAb-ODN conjugate
2018
Abstract 5052: ID3 mediated vascular reprogramming of PCB exposed endothelial cells and its potential contribution to lung tumorigenicity
2018
Exosomal ID3 is pro-metastatic through guiding NRF1-induced breast cancer stem cells across the blood-brain-barrier
2018
Identifying the regulatory network structure of the genes involved in signaling pathways underlying ER-PR-HER2+breast cancer using Bayesian modeling of genome-wide NRF1 DNA motif sequence-enriched genes
2018
Micro RNA-200C is one of the important Fanconi Anemia (FA) pathway downstream regulators in lung cancer
2018
N-glycosylation modulates endothelial cell receptor tyrosine kinase VEGFR-2 ligand-dependent activation and signaling
2018
Role of NRF1 regulatory gene-networks in glioblastoma
2018
TTFields and radiosurgery for 1 to 10 brain metastases from NSCLC in the phase III METIS study
2018
Abstract P4-06-05: Not presented
2018
Abstract P6-05-01: Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/SOX2/miR-302b mediated malignant progression
2018
Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/SOX2/miR-302b mediated malignant progression
2018
Abstract 1552: Integrative bioinformatics analyses of ChIP seq and RNA seq data reveals a complex regulatory landscape of NRF1 network involved in the pathogenesis of breast cancer
2017
Abstract 1700: Radiation-induced vegf-targeted 4-1bb costimulation enhances immune control of tumor growth
2017
Abstract 4442: micoRNA in FA defective tumor
2017
Abstract 848: Netropsin blocks EMT of murine BRAF mutated melanoma cells
2017
Magnetoelectric nanoparticles for high-specificity treatment of cancer
2017
The role of immunogenic SPANX antigens in distinct cancer stem cell subsets within triple negative breast cancers
2017
Vascular endothelial growth factor receptor-2 (VEGFR-2) N-glycosylation modulates angiogenic signaling
2017
Identification of a cancer stem sell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
2017
Abstract 2114: Glycosyltransferase ST6Gal-I protects against chemotherapy induced DNA damage and subsequent apoptosis in pancreatic adenocarcinoma cells
2016
Abstract 2204: Targeted, controlled anticancer drug delivery and release with magnetoelectric nanoparticles
2016
Abstract 3322: Estrogen and nuclear respiratory factor 1 act as joint mediators of redox modulation and stem cell aging that contribute in the pathogenesis of breast cancer
2016
Abstract 3327: The tumor associated sialyltransferase ST6Gal-I promotes a cancer stem cell phenotype and upregulates stem-related transcription factors
2016
Abstract 4438: Promoter hypermethylation status of Fanconi Anemia (FA) pathway genes FANCF, FANCL and FANCS in non-small cell lung cancer (NSCLC)
2016
Abstract 4992: Development of a novel radiation-induced targeted immunotherapy strategy through oligonucleotide aptamer conjugation
2016
Magnetoelectric particles cross blood brain barrier to deliver anti-tumor peptide to glioblastoma cells with on-demand release
2016
VEGF-receptor antagonist, Sugen 5416, sensitizes pulmonary endothelial stem-like cells to estrogens: A microvascular model for the progression of lung cancer
2016
A novel mechanism for field-controlled high-specificity targeted anticancer drug delivery and on-demand release using magnetoelectric nanoparticles
2016
Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy
2015
Id3 generated cancer stem-like cells: A microvascular niche for the development of glioma
2015
Inhibition of pro-survival pathways in lung cancer cells with functional defects in the Fanconi Anemia pathway
2015
Overexpression of NRF1 leads to the generation of cancer stem-like cells and resistance to anoikis _ pathways to anchorage-independent growth during estrogen-induced malignant transformation
2015
Phosphodeficient NRF1 mutant suppresses the susceptibility of the breast epithelial cells to develop tumors when exposed to estrogen - a major breast cancer risk factor
2015
Cancer risk in World Trade Center rescue and recovery workers
2014
ID3 expression and oxidative DNA damage are associated with growth of benign and malignant vascular lesions
2014
Redox signaling to nuclear respiratory factor-1 proteins by reactive oxygen species contributes to the estrogen-induced breast tumor development
2014
Therapeutic targeting of distinct subsets of cancer stem cells within triple negative breast cancers
2014
Ultraviolet radiation induces carcinogenesis in a novel transgenic mouse model of melanoma
2014
Abstract 2563: Identification and functional characterization of a novel UGT2A1 splice variant: Potential importance in tobacco-related cancer susceptibility .
2013
Abstract 3089: miR-491-3p regulation of the UDP-glucuronosyltransferase (UGT) 1A gene family.
2013
Abstract 3633: Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium.
2013
Abstract 4221: Mutations in Rad51C in colon tumors.
2013
Abstract 4246: Promoter hypermethylation and gene expression of FANCF in non-small cell lung cancer (NSCLC).
2013
Abstract 4365: Sensitivity of small cell lung cancer cells with defective Fanconi Anemia (FA) pathway to BCL2 inhibitors..
2013
Abstract 4439: Targeting FANCD2 as a radiosensitizer in pediatric rhabdomyosarcoma.
2013
Abstract LB-139: Phase I trial of veliparib or mitomycin (MMC) + veliparib in patients with sporadic solid tumors screened for somatic deficiency in the Fanconi Anemia (FA) pathway.
2013
PCB153-induced angiogenesis depends on redoxsensitive Pyk2 signaling.
2013
UV radiation interacts with Endothelin 3 and loss of nucleotide excision repair pathway to promote melanomagenesis.
2013
Abstract P4-13-02: Comparing data quality of client intake forms by interview mode: results of a pilot study on the use of audio computer-assisted self-interview (ACASI) in the Avon Breast Health Outreach Program
2012
Abstract 4082: Global miRNA expression changes induced by HDAC-42 and 5-azaCdr in lung cancer cells
2012
Abstract 4460A: Meat-related compounds and colorectal cancer risk by anatomical subsite
2012
Abstract 4682: Compensatory activation of alternative DNA repair pathways following exposure to the PARP Inhibitor ABT-888 in vitro and in patients with solid malignancies
2012
Abstract 4740: Establishment of P53 mutant type specific spontaneous lung tumor in transgenic mice for treatment
2012
Abstract 510: Identification and characterization of immunogenic epitopes from CD133 and their potential for use to immunologically target cancer stem cells
2012
CD44(+)CD24(low+) progenitors in ER negative breast cancer have higher Notch1 activation, self-renewal, and chemo resistance and generate CD44(+)CD24(neg) cells and tumors that metastasize
2012
RTOG 0320:A phase Ill trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases
2012
Stroma-mediated DNA damage resistance of human breast cancer
2012
Early Detection of Cardiotoxicity by Advanced Cardiac Imaging and a Novel Biomarker in Breast Cancer Patients Undergoing Chemotherapy.
2011
Abstract 2757: Characterization of the glucuronidation of the major nicotine metabolite, 3’-hydroxycotinine: Potential role for knock-out polymorphisms in UGTs 2B17 and 2B10
2011
Abstract 5500: Inhibition of poly(ADP-ribose) polymerase in lung cancer cells with defective Fanconi anemia (FA) pathway
2011
Abstract 610: Regression of spontaneous non-small cell lung cancers in P53 mutant transgenic mice following exposure to PRIMA-1
2011
Estrogen-induced redox signaling via NRF-1 is involved in the development of breast cancer
2011
Primary cultures established from estrogen receptor negative breast tumors: Method and characterization
2011
Self-renewal, tumorigenicity and metastatic potential of CD44+cells in ER-negative lines and dissociated primary human breast cancers is increased in CD24+subsets
2011
Abstract P6-15-08: KGFR Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
2010
Abstract 1698: Characterization of the activity and expression of UDP-Glucuronosyltransferase 2A1 variants and potential role in tobacco carcinogenesis
2010
Abstract 2828: Examination of two approaches to assess dietary patterns in relation to colorectal cancer risk
2010
Abstract 3456: Characterization of dibenzo[ a,l ]pyrene- trans -11,12-diol glucuronidation by UDP-glucuronosyltransferases
2010
Abstract 3589: Characterization of 17-dihydroexemestane glucuronidation. A role for the UGT2B17 deletion in exemestane pharmacogenetics
2010
Abstract 3750: Functional analysis of the Fanconi Anemia pathway in primary lung tumors
2010
Abstract 4826: International Lung Cancer Consortium: Pooled analysis of previous lung diseases and lung cancer risk
2010
Abstract 5050: Functional characterization of a newly identified growth regulatory gene SKCG-1 in human kidney cancer
2010
Abstract 5178: Homing of circulating prostate cancer cells to bone is regulated by alpha 1,3 fucosyltransferase 7
2010
Abstract 604: Erucin treatment through induction of thioredoxin reductase may alter tamoxifen resistance in LCC2 cells
2010
Abstract 918: Glucuronidation genotypes and nicotine metabolic phenotypes: Importance of UGT2B10 and UGT2B17 knock-out polymorphisms
2010
N-glycosylation in cultured cells and hepatocellular carcinoma
2010
Redox Status Contributes to Tamoxifen-Resistant Growth of Breast Cancer.
2009
Estrogenic PCBs increase blood vessel formation by redox signaling
2009
NRF-1 signaling participates in the estrogen-mediated growth of breast cancer cells.
2009
Suppression of Relaxin receptor RXFP1 in Prostate Cancer Cells Decreases Tumor Growth and Metastasis in vivo
2009
Colorectal cancer disparities by race/ethnicity and socioeconomic status in south Florida
2006
Estrogen-induced ROS signaling molecules and their role in brain cancer
2006
Structure activity relation study of small-molecule antagonists of apoptosis suppressor XIAP
2006
Galectin-Binding O-Glycosylations as Regulators of Malignancy
2015
The microculture-kinetic (MiCK) assay: The role of a drug-induced apoptosis assay in drug development and clinical care
2012
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.
2024
Efficacy of a functional precision medicine approach in relapsed/refractory pediatric cancer patients: results from a prospective clinical study
2023
Checkpoint Kinase I, Cyclin E1, and Exonuclease I genes play role in the survival of lung adenocarcinoma patients
2023
Differential CD45 isoform expression and function in AML versus healthy leukocytes
2023
ID3 controlled dynamic Pyk2 localization is important for the mobility of cancer stem cells
2023
The metastasis-suppressive function of intracellular galectin-3 in melanoma
2023
Origanum majorana
organic extract induces senescence and autophagic cell death in breast cancer cells through influencing mitochondrial metabolism
2016
Association between serum concentrations of polychlorinated biphenyls (PCBs) and increased risk of breast cancer among US women
2016
Targeted, controlled anticancer drug delivery and release with magnetoelectric nanoparticles
2016
Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.
2015
Role of endothelin 3 in melanoma progression and metastasis
2013
FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma.
2010
Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
2009
Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.
2009
Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism.
2007
Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
2004
Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
2002
Insulin-like growth factor 1 receptors are increased in estrogen-induced kidney tumors.
1993
Research
category
ONCOLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
0008-5472
Electronic International Standard Serial Number (EISSN)
1538-7445
Other
journal abbreviation
CANCER RES
